Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 11:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 2,611 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Neonatal Respiratory Distress
Interventions: RAM Nasal Cannula; Other
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 28 Weeks to 42 Weeks
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Photodamaged Skin, Skin Care
Interventions: Topical Body Firming Moisturizer, Body Cleanser, Sunscreen, Placebo Moisturizer; Other
Lead sponsor: Revision Skincare; Industry
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Pain, Postoperative
Interventions: Ketorolac Tromethamine, Morphine Sulfate, Intravenous Placebo for NTM-001, IV Placebo for Morphine; Drug · Other
Lead sponsor: Neumentum, Inc.; Other
Eligibility: 18 Years to 64 Years
Enrollment: 341 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 10
States / cities: Sun City, Arizona • Bakersfield, California • Canoga Park, California + 7 more

Conditions: Smoking Cessation
Interventions: Tech-Facilitated IC Intervention, VA Quitline; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 45 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes Mellitus, Type 2, Hypoglycemia
Interventions: FreeStyle Libre 2 CGM, FreeStyle Libre Pro blinded CGM, FreeStyle Precision Neo blood glucose meter; Device
Lead sponsor: Palo Alto Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Palo Alto, California • Atlanta, Georgia

Conditions: Plaque Psoriasis
Interventions: tapinarof cream, 1%; Drug
Lead sponsor: Organon and Co; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 763 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 85
States / cities: Birmingham, Alabama • Phoenix, Arizona • Bryant, Arkansas + 74 more

Conditions: Drug Toxicity Psychotropic Agents Psychostimulants
Interventions: Ryanodex (dantrolene sodium) for injectable suspension; Drug
Lead sponsor: Eagle Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Tissue and Organ Procurement, Alcohol Abstinence
Interventions: Organ Donor, Alcohol Prevention; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 14 Years to 19 Years
Enrollment: 429 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Bacterial Vaginosis
Interventions: LACTIN-V, Placebo control substance; Drug
Lead sponsor: Osel, Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: CAR T-Cell Therapy
Interventions: THRIVE-CAR-T; Behavioral
Lead sponsor: Patrick C. Johnson, MD; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rhytides, Wrinkle
Interventions: Venus Viva; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 22 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Atopic Dermatitis, Psoriasis
Interventions: Phone calls, Desoximetasone 0.25% spray; Behavioral · Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Allergy, Hypersensitivity, Immediate, Ig-E Mediated Food
Interventions: AllerTest-10 Multi-Head Skin Test Device, Skintestor OMNI Multi-Head Skin Test Device, Multi-Test II Multi-Head Skin Test Device, AllerTest-8 Multi-Head Skin Test Device; Device
Lead sponsor: QHSLab, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Wounds and Injuries
Interventions: Processed Amniotic Fluid, Standard of Care Wound Treatment Regimen; Drug · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Alcohol; Use, Problem, Stress, Binge Eating, Depression
Interventions: behavioral activation; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 17 Years and older
Enrollment: 572 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Fibromyalgia
Interventions: Gabapentin, Osteopathic Manipulative Medicine, Gabapentin and Osteopathic Manipulative Medicine; Drug · Procedure · Other
Lead sponsor: Good Samaritan Regional Medical Center, Oregon; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Vallejo, California

Conditions: Depression
Interventions: Esketamine, Cognitive Behavioral Therapy (CBT), Antidepressant; Drug · Behavioral
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: New Haven, Connecticut • Chicago, Illinois • Baltimore, Maryland + 1 more

Conditions: Surgery, Geriatric Assessment, Health Services Research, Implementation Science
Interventions: Implementation Package for CGA, Routine Clinical Care; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Child, Preschool, Child, Adolescent
Interventions: COHORT A: Actigraph, Panoramic Bracelet and GENEActiv; Device
Lead sponsor: Pfizer; Industry
Eligibility: 3 Years to 17 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Skin Care
Interventions: Retinol Complex 0.5, Facial cleanser, Moisturizing lotion, Sunscreen, Skin Imaging; Other · Device
Lead sponsor: Allergan; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Irvine, California

Conditions: Dementia With Lewy Bodies, Parkinson Disease Dementia, Healthy Controls
Interventions: Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims, Plasma biomarkers, Galantamine HBr extended-release 8mg capsules (8mg ER).; Procedure · Diagnostic Test · Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 50 Years to 89 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Dementia, Alzheimer Type
Interventions: ABC Clinical Program, BCN; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Cannabis Use Disorder
Interventions: Active rTMS, Sham rTMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Lung Cancer, Esophageal Cancer, Thoracic Cancer, Hodgkin Lymphoma, Hodgkin Disease, Non-hodgkin Lymphoma, Sarcoma, Thymoma, Breast Cancer
Interventions: Home-based cardiac rehabilitation; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU)

A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming

Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

Tech and Telephone Smoking Cessation Treatment for Young Veterans With PTSD

FreeStyle Libre 2 Discharge Trial

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Intervention to Motivate Teens to be a Designated Organ Donor on Driver's License

Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis

THRIVE-CAR-T Digital App

Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

Evaluating Treatment Resistant Dermatitis TaroIIR

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds

A Behavioral Activation Intervention Administered in a College Freshman Orientation Course

Fibromyalgia Treatment Trial With Gabapentin and Osteopathic Manipulative Medicine

A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression

Implementation Pilot of Preoperative CGA Before Major Surgery

Monitoring Activity And Gait In Children

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)

A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers